Acura Pharmaceuticals $11.4M Debt Financing with Abuse Deterrent Pharma, LLC
Acura Pharmaceuticals received two new loans totaling $141,607 from Abuse Deterrent Pharma, LLC, which were consolidated into an existing secured promissory note now totaling approximately $11.44 million in principal. The company warned that without additional financing by late November 2026, it may be forced to scale back operations, lay off employees, or seek bankruptcy protection.
Acura Pharmaceuticals $11.3M Debt Financing with Abuse Deterrent Pharma, LLC
Acura Pharmaceuticals received two $100,000 loan tranches from Abuse Deterrent Pharma, LLC, bringing the total principal balance of its secured promissory note to $11,294,279. The company warned that without additional financing by mid-October 2026, it may be forced to furlough employees, terminate operations, or seek bankruptcy protection.